The Potential of Nichi Glucan as a Vaccine Adjuvant

A paper describing the potentials of Nichi Glucan as a vaccine adjuvant to COVID-19 has been published in Human Vaccines and Immunotherapeutics, a journal sponsored by the International Society of Vaccines.

Clinical studies in Covid-19 and its variants to tackle the pandemic, recommended.

To read the press release in Business Wire, click here.

Please visit for more information about Nichi Glucan.


Other Press release